Is Dr Agarwal's Hea overvalued or undervalued?
As of August 29, 2025, Dr Agarwal's Healthcare is considered overvalued with a PE ratio of 160.07, a low ROE of 4.58%, and a PEG ratio of 0.00, indicating no expected growth, while its stock performance has lagged behind the Sensex.
As of 29 August 2025, Dr Agarwal's Healthcare has moved from a valuation grade of very expensive to expensive. The company is currently considered overvalued based on its high valuation ratios. The PE ratio stands at 160.07, significantly higher than its peers, with Apollo Hospitals at 69.47 and Narayana Hrudaya at 45.26. Additionally, the EV to EBITDA ratio for Dr Agarwal's is 30.97, compared to Apollo Hospitals' 35.76, indicating a premium valuation despite its high PE.The company's return on equity (ROE) is at a low 4.58%, which raises concerns about its profitability relative to its market price. With a PEG ratio of 0.00, it suggests there is no growth expected, further supporting the overvaluation stance. The recent stock performance has lagged behind the Sensex, with a 1-week return of -4.31% compared to the Sensex's -1.84%, reinforcing the notion that the stock is not performing well relative to the broader market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
